Connecting the Dots Between Fatty Acids, Mitochondrial Function, and DNA Methylation in Atherosclerosis

Area of Science:

• Epigenetics
• Cardiovascular Disease Biology
• Mitochondrial Metabolism

Background:

• Aberrant DNA methylation is implicated in human diseases, including atherosclerosis.
• Fatty acids (FAs) are increasingly recognized as critical regulators of epigenetic modifications.
• Mitochondrial dysfunction is linked to chronic degenerative diseases.

Purpose of the Study:

• To review the role of fatty acids (FAs) in modulating DNA methylation.
• To investigate the specific role of mitochondrial beta-oxidation in FA-induced DNA methylation changes during atherosclerosis.
• To explore the connection between lipid metabolism, mitochondrial function, and DNA methylation in atherosclerosis.

Main Methods:

• Literature review of recent publications on DNA methylation, fatty acids, and atherosclerosis.
• Analysis of studies linking lipid composition, mitochondrial function, and epigenetic changes.
• Synthesis of evidence connecting FA dynamics, mitochondrial activity, and DNA methylation patterns.

Main Results:

• Lipids play a causal role in shaping the DNA methylome.
• Chronic degenerative diseases are associated with impaired mitochondrial function.
• DNA hypermethylation is relevant in the context of atherosclerosis.
• Emerging evidence links FA abundance, mitochondrial function, and DNA methylation in atheroma and systemically.

Conclusions:

• Mitochondrial beta-oxidation is highlighted as a significant regulator of DNA methylation in metabolic diseases.
• Understanding these mechanisms may identify factors contributing to pathological gene expression in atherosclerosis.
• This research area holds promise for uncovering novel therapeutic targets for atherosclerosis.